Approaches to the rational design of selective melanocortin receptor antagonists

By Hruby Victor J   Cai Minying   Nyberg Joel   Muthu Dhanasekaran  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 543-557

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of new pyrrolo[1,2-a]quinoxalines: potential non-peptide glucagon receptor antagonists

By Guillon J.   Dallemagne P.   Pfeiffer B.   Renard P.   Manechez D.   Kervran A.   Rault S.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 4, 1998-04 ,pp. : 293-308

Elsevier

Access to resources Recommend Favorite

A survey of small molecule glucagon receptor antagonists from recent patents (2006 –– 2010)

By Shen Dong-Ming   Lin Songnian   Parmee Emma R  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1211-1240

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 21-30

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon antagonists for the treatment of Type 2 diabetes

By Connell R.D.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 701-709

Informa Healthcare

Access to resources Recommend Favorite